Found 24 matching trials
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA PHASE3 The primary objective of this study is to assess the efficacy of fostamatin...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies PHASE1 Background:
People who have lung transplants often survive 6 or 7 years. B...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus PHASE2 Approximately 225 patients meeting study entry requirements will be enrolle...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) PHASE2 The purpose of this study is to determine whether the Spleen Tyrosine Kinas...
Show More Location
Arthritis & Rheumatic Disease Specialties
Learn More & Join Trial
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. PHASE3 The purpose of the study is to evaluate the effectiveness of two dosing reg...
Show More Learn More & Join Trial
A Study to Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects PHASE1 This is a single and multiple ascending dose study in healthy male and fema...
Show More Learn More & Join Trial
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis PHASE2 The purpose of this study is to determine whether the Spleen Tyrosine Kinas...
Show More Location
Divison of Rheumatology Allergy and Immunology
Learn More & Join Trial
Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1) PHASE2 This is a Phase II, multicenter, randomized, double-blind, placebo-controll...
Show More Location
Pacific Arthritis Center Medical Group
Learn More & Join Trial
Fostamatinib for Hospitalized Adults With COVID-19 PHASE2 Background:
COVID-19 is a new disease caused by SARS-CoV-2 that was identi...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis PHASE2 The purpose of this study is to evaluate the effect of fostamatinib compare...
Show More Learn More & Join Trial